Lipoprotein (a) metabolism estimated by nonsteady-state kinetics

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Lipids

• Publication date

  1999-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s11745-999-0370-zPMID 10443965
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Low-density lipoprotein-apolipoprotein B metabolism following apheresis: simulation studies of mass changes and tracer kinetics.

  1998cited by this paper
• Apolipoprotein E polymorphism has no independent effect on plasma levels of lipoprotein(a).

  1997cited by this paper
• 4.P.315 Stimulation of LDL receptor expression by LDL-immuno-apheresis in patients with heterozygous familial hypercholesterolemia

  1997cited by this paper
• Renovascular arteriovenous differences in Lp[a] plasma concentrations suggest removal of Lp[a] from the renal circulation.

  1997cited by this paper
• Effects of weekly LDL-apheresis on metabolic parameters of apolipoprotein B in heterozygous familial hypercholesterolemia.

  1996cited by this paper
• The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans.

  1995cited by this paper
• Lipoprotein(a) concentrations and phenotypes in controls and patients with hypercholesterolemia or hypertriglyceridemia.

  1994cited by this paper
• The inverse association of plasma lipoprotein(a) concentrations with apolipoprotein(a) isoform size is not due to differences in Lp(a) catabolism but to differences in production rate.

  1994influential reference
• Variation in lipoprotein(a) concentrations among individuals with the same apolipoprotein (a) isoform is determined by the rate of lipoprotein(a) production.

  1993influential reference
• Three-year treatment of familial heterozygous hypercholesterolemia by extracorporeal low-density lipoprotein immunoadsorption with polyclonal apolipoprotein B antibodies.

  1993cited by this paper
• Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations.

  1992cited by this paper
• Determination of kinetic parameters of apolipoprotein B metabolism using amino acids labeled with stable isotopes.

  1991cited by this paper
• Lipoprotein (a). Heterogeneity and biological relevance.

  1990cited by this paper
• Polymorphic forms of human apolipoprotein[a]: inheritance and relationship of their molecular weights to plasma levels of lipoprotein[a].

  1990cited by this paper
• Nonuniform radiolabeling of VLDL apolipoprotein B: implications for the analysis of studies of the kinetics of the metabolism of lipoproteins containing apolipoprotein B.

  1990cited by this paper
• Effect of HELP‐LDL‐apheresis on serum concentrations of human lipoprotein(a): kinetic analysis of the post‐treatment return to baseline levels

  1989cited by this paper
• The mysteries of lipoprotein(a).

  1989cited by this paper
• Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma.

  1987influential reference
• Statistical methods for assessing agreement between two methods of clinical measurement.

  1986cited by this paper
• Clinical biostatistics: LIV. The biostatistics of concordance

  1981cited by this paper
• Turnover of lipoprotein (a) in man.

  1980cited by this paper

• Diabetes Mellitus and Lipoprotein(a): A Determinant Interaction in Micro- and Macrovascular Damage

  2025cites this paper
• Familial hypercholesterolaemia.

  2024cites this paper
• Thematic Lipoprotein (a): Coming of Age at Last Lipoprotein apheresis to treat elevated lipoprotein (a) 1

  2020cites this paper
• Lipoprotein (a) and Low‐density lipoprotein apolipoprotein B metabolism following apheresis in patients with elevated lipoprotein(a) and coronary artery disease

  2018cites this paper
• Effects of mipomersen, an apolipoprotein B100 antisense, on lipoprotein (a) metabolism in healthy subjects[S]

  2018cites this paper
• Increased Production Rate of Apolipoprotein(a) is the Primary Mechanism for Increased Lipoprotein(a) Concentration in Patients with Hypercholesterolaemia on Statin Therapy

  2017cites this paper
• Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy Humans

  2017cites this paper
• The metabolism of lipoprotein (a): an ever-evolving story

  2017cites this paper
• INDICATIONS FOR LIPOPROTEIN APHERESIS

  2016cites this paper
• Effects of Extended-Release Niacin on the Postprandial Metabolism of Lp(a) and ApoB-100–Containing Lipoproteins in Statin-Treated Men With Type 2 Diabetes Mellitus

  2015cites this paper
• Effects of Lipoprotein apheresis on the Lipoprotein(a) levels in the long run.

  2015cites this paper
• Lipoprotein(a) metabolism: potential sites for therapeutic targets.

  2013cites this paper
• Lipoproteína (a) está asociada a niveles basales de insulina en pacientes con Diabetes Mellitus tipo 2

  2009cites this paper
• Lipoprotein (a) is associated with basal insulin levels in patients with type 2 Diabetes Mellitus.

  2009cites this paper
• Apheresis in Coronary Heart Disease With Elevated Lp (a): A Review of Lp (a) As a Risk Factor and Its Management

  2007cites this paper
• Lipoprotein(a). The bad cholesterol.

  2004cites this paper
• In vivo metabolism of LDL subfractions in patients with heterozygous FH on statin therapy: rebound analysis of LDL subfractions after LDL apheresis.

  2004cites this paper
• Lipids and lipoprotein(a) concentrations in Pakistani patients with type 2 diabetes mellitus

  2004cites this paper
• Hormonal influences on lipoprotein(a) metabolism

  2002cites this paper